Dr. Daniel J. Aires, M.D.
Dermatology (Dermatology Physician)
3901 Rainbow Blvd, Dept Of Internal Medicine
Kansas City, KS 66160
- Medicare participating
At a glance
- Medical school
- Yale University School of Medicine (1998)
- Years since graduation
- 28
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 466
Licensed in California since 2019, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1998Medical school: Yale University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
CA license C166853 (first issued 2019; current) · KS license 04-31416
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Golden State Dermatology Associates, Inc. (125 clinicians)
- Kansas Medical Clinic PA (48 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 466
- Services billed
- 4,892
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 789 | 97 |
| Destruction of skin growth, 1-14 growths | 194 | 120 |
| Destruction of precancer skin growth, 1 growth | 193 | 116 |
| Established patient office or other outpatient visit, 20-29 minutes | 180 | 126 |
| Established patient office or other outpatient visit, 30-39 minutes | 163 | 126 |
| Established patient office or other outpatient visit, 10-19 minutes | 82 | 62 |
| Destruction of precancer skin growth, 15 or more growths | 76 | 42 |
| Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 50 | 41 |
| New patient office or other outpatient visit, 45-59 minutes | 42 | 42 |
| Biopsy of related skin growth, first growth | 38 | 38 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Ketoconazole Other prescribers in Kansas City, KS | 262 |
| Azelaic Acid | 149 |
| Mupirocin Other prescribers in Kansas City, KS | 106 |
| Triamcinolone Acetonide Other prescribers in Kansas City, KS | 87 |
| Ammonium Lactate Other prescribers in Kansas City, KS | 84 |
| Clindamycin Phosphate Other prescribers in Kansas City, KS | 45 |
| Hydrocortisone Other prescribers in Kansas City, KS | 40 |
| Clobetasol Propionate Other prescribers in Kansas City, KS | 39 |
| Calcipotriene | 32 |
| Valacyclovir (valacyclovir hcl) Other prescribers in Kansas City, KS | 29 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 16 companies reported 45 payments worth $20,804 in total to this clinician.
| Therakos LLC | $20,045 |
|---|---|
| AbbVie Inc. | $124 |
| Lilly USA, LLC | $118 |
| UCB, Inc. | $102 |
| Regeneron Healthcare Solutions, Inc. | $65.36 |
| Genzyme Corporation | $62.55 |
| Incyte Corporation | $51.01 |
| Organon LLC | $49.28 |
| Compensation for services other than consulting (speaking, faculty) | $18,285 |
|---|---|
| Travel and Lodging | $1,346 |
| Food and Beverage | $1,173 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Therakos LLC Nov 24, 2025 | Compensation for services other than consulting (speaking, faculty) Uvadex; CELLEX · Critical Care | $11,925 |
| Therakos LLC Sep 2, 2025 | Compensation for services other than consulting (speaking, faculty) Uvadex; CELLEX · Critical Care | $6,360 |
| Therakos LLC Nov 13, 2025 | Travel and Lodging Uvadex; CELLEX · Critical Care · travel to New Orleans, LA · in-kind | $737 |
| Therakos LLC Nov 13, 2025 | Travel and Lodging Uvadex; CELLEX · Critical Care · travel to New Orleans, LA · in-kind | $211 |
| Therakos LLC Nov 14, 2025 | Travel and Lodging Uvadex; CELLEX · Critical Care · travel to Piedmont, CA | $146 |
| Therakos LLC Nov 13, 2025 | Travel and Lodging Uvadex; CELLEX · Critical Care · travel to San Francisco, CA | $86.18 |
| Therakos LLC Nov 13, 2025 | Travel and Lodging Uvadex; CELLEX · Critical Care · travel to New Orleans, LA | $65.24 |
| Therakos LLC Nov 14, 2025 | Travel and Lodging Uvadex; CELLEX · Critical Care · travel to Kenner, LA | $59.27 |
| Therakos LLC Nov 13, 2025 | Travel and Lodging Uvadex; CELLEX · Critical Care · travel to New Orleans, LA | $27.59 |
| Therakos LLC Nov 14, 2025 | Travel and Lodging Uvadex; CELLEX · Critical Care · travel to New Orleans, LA | $13.49 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.